Pacific Biosciences of California PACB Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Consumable revenue | $83.66M+2.1% | $81.94M+3.6% | $79.12M+3.6% | $76.35M+2.5% | $74.49M+5.8% | |
| Instrument revenue | $52.52M-2.4% | $53.82M+4.0% | $51.77M-9.6% | $57.24M-0.9% | $57.77M-12.2% | |
| Total Revenue by Geography | ||||||
| Americas | $73.18M+0.5% | $72.8M+0.8% | $72.26M-2.7% | $74.27M-4.0% | $77.34M-1.7% | |
| Asia-Pacific | $41.27M-4.4% | $43.16M+0.9% | $42.77M-2.6% | $43.92M+11.1% | $39.54M-2.9% | |
| Europe, Middle East and Africa | $45.58M+3.5% | $44.05M+11.4% | $39.56M+4.3% | $37.92M+6.9% | $35.48M+2.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Pacific Biosciences of California break its business down?
- Pacific Biosciences of California (PACB) reports total revenue by product across 3 parts — Consumable revenue, Instrument revenue and Service and other revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Pacific Biosciences of California's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Pacific Biosciences of California's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
